Edward Young Labs

Name

Edward Young Labs

Legal name

Edward Young Labs

Website

https://edwardyounglabs.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB)

akta.pro secondary industry

CMC & Pharmaceutical Development (Formulation/Process/Analytical Development) (HLAIALAD)

Keywords

• Pharmaceutical manufacturing
• PCD pharma franchise
• Pharmaceutical formulations
• Third-party manufacturing
• Generic medicines distribution

Headquarters

HQ city

Chandigarh

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales

Revenue model

1. PCD Pharma Franchise: Edward Young Labs generates revenue through its PCD (Propaganda Cum Distribution) pharma franchise model, offering pharmaceutical products including Tablets, Capsules, Softgels, Liquid, Dry Syrup, and Injections to distribution partners across India.
2. Third Party Manufacturing: The company operates third-party manufacturing services for pharmaceutical formulations.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Edward Young Labs is a WHO GMP certified PCD (Propaganda Cum Distribution) pharma franchise company that manufactures and distributes pharmaceutical formulations including tablets, capsules, softgels, liquids, dry syrups, and injections across multiple therapeutic categories. The company operates its own manufacturing facility in Baddi (Himachal Pradesh) and R&D center, and also offers third-party pharmaceutical manufacturing services to other pharma companies in India.

Product overview

Edward Young Labs is a WHO GMP Certified PCD (Propaganda Cum Distribution) Pharma Franchise Company based in Chandigarh, India, operating as a single unified pharmaceutical product portfolio rather than a platform-plus-modules architecture. The company manufactures and distributes a comprehensive range of pharmaceutical formulations including Tablets, Capsules, Softgels, Liquids, Dry Syrups, and Injections. Their product portfolio spans multiple therapeutic categories including Antibiotics, Orthopedics, Dental, Gynecology, Derma Products, Neurology, Gastrointestinal, Hepatology, Antiallergics, Antimalarial, Anabolic, Diabetic, and Nutritional Supplements. The featured individual products like CEWAT S 1.5 GM, EDI-PHYLIN 200 SR, FAPIC-GOLD SF, HONEY-IN COUGH SYP, KETOWARD Shampoo, and LOWIP-10 represent their key branded formulations, while the company also organizes products by 15+ therapeutic categories on their website. With over 16 years of industry experience and own manufacturing facilities and R&D capabilities, the company operates as both a PCD franchise provider and third-party manufacturing partner.

Differentiator

Problem solved

Functional benefit

Products and services

• CEWAT S 1.5 GM Pharmaceutical tablet formulation featured as a top brand in the company's portfolio, manufactured for distribution through PCD pharma franchise partners.
• EDI-PHYLIN 200 SR Sustained-release tablet formulation listed among the company's featured pharmaceutical offerings for franchise distribution.
• FAPIC-GOLD SF Pharmaceutical formulation product featured in the company's delivery excellence product showcase.
• HONEY-IN COUGH SYP Cough syrup formulation containing honey as a key ingredient, classified under anticold/expectorant/antitussive category for franchise distribution.
• KETOWARD Shampoo Ketoconazole shampoo product for dermatological use, featured as a key product in Edward Young Labs' portfolio.
• LOWIP-10 Levocetirizine 10 MG tablet, an anti-histamine/anti-allergic medication packaged in ALU ALU format with 10x10 packing configuration.
• PCD Pharma Franchise Services Propaganda Cum Distribution franchise service offering pharmaceutical products including Tablets, Capsules, Softgels, Liquid, Dry Syrup, and Injections to distribution partners across India, with free promotional materials and reasonable rates.
• Third-Party Pharmaceutical Manufacturing Contract manufacturing services for pharmaceutical formulations at the company's WHO GMP, ISO 9001:2015, and GLP certified facility in Baddi, Himachal Pradesh.

Named customers5 records

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators1 record

Recent moves5 records

Expansion highlights3 records

Broad incumbents

• Sun Pharma: India's largest pharmaceutical company with a broad generics portfolio. Listed as a partner on Edward Young Labs' website; relevant as a broader incumbent shaping the same market in which EYL's franchise partners operate.
• Cipla: Large established Indian pharmaceutical manufacturer with a national generics and OTC portfolio across many of the same therapeutic categories (anti-allergic, respiratory, gastro, derma) that Edward Young Labs serves.
• Mankind Pharma: Major Indian pharma company with an extensive PCD franchise network and broad OTC/generics footprint; overlaps directly with Edward Young Labs' franchise-led distribution approach at much larger scale.

Direct peers

• Healthkind Labs: Chandigarh-region PCD franchise pharma company manufacturing tablets, capsules, syrups and injectables; directly comparable in geography, GTM, and therapeutic breadth.
• Centurion Healthcare: Mid-sized Indian PCD franchise pharma company with multi-category generics and own manufacturing; comparable product breadth and distribution-driven GTM.
• Daffohils Laboratories: PCD pharma franchise operator with WHO GMP-certified manufacturing in North India, serving similar franchise partner base with generic formulations across multiple therapeutic categories.
• Apcon Pharma: PCD pharma franchise manufacturer in India with broad multi-therapeutic product lines and third-party manufacturing services; directly competing for the same franchise partner segment.
• Biophar Lifesciences: Indian franchise pharma player offering a wide therapeutic portfolio through PCD partners with own manufacturing; mirrors Edward Young Labs' operating model and category mix.
• Acme Lifetech Labs: Indian PCD pharma franchise and third-party manufacturer offering tablets, capsules, dry syrups and injectables. Direct comp to Edward Young Labs on GTM model (franchise distribution) and product format.
• Saffron Medicare: North-Indian PCD franchise pharma manufacturer with multi-category branded generics and franchise partner network; comparable scale, marketing approach and WHO-GMP positioning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/edward-young-labs

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Edward Young Labs